Outlining five questions that should be considered when assessing if RWD is “fit for purpose” in pharma research—and ultimately clinical and pharmacy decision support
Nancy Dreyer, IQVIA
Advertisement
Articles by Nancy Dreyer, IQVIA
Advertisement
Latest Updated Articles
The True Reliability of Real-World DataPublished: August 23rd 2021 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
Mark Cuban Pushes for Generic Drug Fee Waivers, as Cost Plus Drugs Eyes US Manufacturing Expansion
2
What MFN Pricing Means for Future Drug Development
3
Strive Pharmacy Breaks Ground on Arizona HQ
4
Cencora Accelerates Global 3PL Expansion With Major Investments in Cold Chain and Specialty Logistics
5
